Partnering
Contact
Contact Information
Join Us
CN
EN
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
Southeast Asia Business
News
Company News
Partner News
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Home
About Us
CMS Overview
Leadership
Milestones
Social Responsibility
Innovation
R&D Overview
Pipeline
Business
Business Overview
Cardio-cerebrovascular and Gastroenterology
Dermatology and Medical Aesthetics
Ophthalmology
News
Company News
Partner News
Investors
Investors
Stock Infomation
Financial Highlights
Information Disclosure
Corporate Governance
Investor Communication
Partnering
Contact
Contact Information
Join Us
CN
EN
Information Disclosure
Announcements and Circulars
Financial Reports
Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-11-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
2023-10-03
CONTINUING CONNECTED TRANSACTIONS RELATED TO DIAZEPAM NASAL SPRAY (VALTOCO) AMENDED TERMS AND REVISED ANNUAL CAPS
2023-09-12
Notification Letter
2023-09-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
2023-09-01
CONTINUING CONNECTED TRANSACTION RELATED TO DIAZEPAM NASAL SPRAY (VALTOCO)
2023-08-28
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2023
2023-08-28
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
2023-08-28
Voluntary and Business Update Announcement Gaining Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
2023-08-24
Notice of Board Meeting
2023-08-16